It was further identified that CD163 was responsible for the improved hematoma resolution effect by CCL17, which included activation of the C-C chemokine receptor 4 (CCR4) with downstream ERK and Nrf2 activation, improving the outcome of intracerebral hemorrhage in a relevant animal model [37]. The gene discussed is CCR4; the disease is intracerebral hemorrhage.